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have shielded the charged groups of the
inositol head group with butyrate and AM
esters, which are subsequently hydro-
lyzed in the cell cytosol. Intriguingly, it
would appear that, despite the inclusion
of a novel phosphate on the 6’ position,
many PIP3 binding and metabolizing
proteins are capable of being recruited
by the PIP4 molecule. Laketa et al. (2009)
show that PIP4/AM is a more potent
stimulator of several PIP3-dependent
processes in the cell than is the related
derivative PIP3/AM, suggesting that the
novel PIP4 is not as accessible to degra-
dative enzymes (such as endogenous 30
or 50 phosphatases) as is PIP3 once cyto-
solic hydrolases have removed the AM
and butyrate groups from the inositol
ring. Using this technique, they are able
to bypass the requirement for growth
factor stimulation and subsequent PI
30-kinase activation, to look directly at
a subset of PI dependent signaling in the
cell, including their feedback onto growth
factor receptors themselves. An exciting
possibility is that the inclusion of the 6’
phosphate group in PIP4 will render this
analog inaccessible to some PIP3 binding
proteins, thus becoming a growth factor-
independent agonist of pathways such
as the PDK1, AKT/PKB pathway, which
is characterized in great detail in this
article.
Use of this new molecule, in combina-
tion with other methods of manipulating
PI metabolism, has the potential to
untangle some of the complex web of
protein modification and signaling feed-
back that growth factor signaling evokes
in models of health and disease.
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RNA stars in many roles within the cell. In a recent paper published in Cell, Loh et al. demonstrate a new
mechanism of action for natural riboswitches and provide important insights into the regulation of virulence
in a pathogenic bacterium.Whether it’s on the big screen or on the
small one, in the lead role or in support,
some actors seem to be able to play any
type of role. Two of the most versatile
actors of today, Christopher Walken and
Meryl Streep, appeared together in the
1978 film ‘‘The Deer Hunter,’’ for which
Walken was awarded an Oscar for Best
Supporting Actor, while Streep was nomi-
nated for Best Supporting Actress. Since
then, both actors have gone on to appear
in countless memorable roles, and I’m1128 Chemistry & Biology 16, November 25never surprised to see them in something
unusual, such as Walken in ‘‘Hairspray,’’
or Streep as Julia Child in ‘‘Julie and Julia.’’
Such versatility appears at the molec-
ular level as well, where RNA is frequently
discovered in new roles. Coincidentally, it
was also in 1978 when Sidney Altman and
coworkers showed that RNA plays an
essential role in the activity of the enzyme
RNase P (Stark et al., 1978). In the three
decades since, we have begun to appre-
ciate the versatility of RNA as it stars in, 2009 ª2009 Elsevier Ltd All rights reservedan increasing variety of roles in biological
systems. Far from being a bit player medi-
ating translation, RNA appears in diverse
starring roles in both eubacteria (Waters
and Storz, 2009) and eukaryotes (Rana,
2007).
The bacterial kingdom also has its share
of versatile players, including the path-
ogen Listeria monocytogenes, which
excels at playing the bad guy. In addition
to being a leading cause of food-borne
illness in humans, L. monocytogenes can
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Previewscross the intestinal barrier, the blood-brain
barrier, and the feto-placental barrier, all
of which can lead to more serious dis-
eases (Lecuit, 2005). Due to its relevance
in disease and its historical role as a model
for host-pathogen interactions, Toledo-
Arana et al. (2009) recently carried out a
comprehensive study of the L. monocyto-
genes transcriptome under a variety of
conditions that mimic its infective cycle.
In doing so, they identified over 50 small
RNAs (sRNAs) that are expressed under
different conditions, including two that
are involved in virulence in a mouse model.
In addition, the authors identified 40
riboswitches, which are RNA sequences
thatdirectly bind tometabolites tomediate
changes in gene expression without the
need for additional protein cofactors.
In a new paper appearing in Cell, Loh
et al. (2009) demonstrate how some of
these riboswitches control the expression
of virulence regulators in L. monocyto-
genes. In addition to providing new
insights into the lifestyle of a pathogenic
bacterium, Loh et al. (2009) demonstrate
a new mechanism of action for ribos-
witches, which has broad implications for
the control of gene expression in a range
of bacteria and possibly other domains
of life as well.
The word ‘‘riboswitch’’ entered the
scientific vernacular in 2002, when it was
demonstrated conclusively that mRNA
sequences could directly bind small-
molecule metabolites to control gene
expression in bacteria (Nahvi et al., 2002).
Over the past several years, a variety of
mechanisms for riboswitch control have
been identified, including those occurring
both co- and posttranscriptionally (Roth
and Breaker, 2009). While their specific
mechanisms of action vary, all natural
riboswitches identified thus far have
been shown to act ‘‘in cis,’’ which is to
say that they mediate the expression of
mRNAs that they are covalently linked to.
Loh et al. (2009) challenged this notion
by considering the fate of 7 riboswitches
that were predicted to respond to the
ubiquitous metabolite S-adenosylmeth-
ionine (SAM). In Gram-positive bacteria,
such as in L. monocytogenes, most
SAM-responsive riboswitches terminatetranscription of downstream genes upon
binding SAM, leaving behind short, non-
coding transcripts. Until now, it has been
largely assumed that these truncated
transcripts did not play further regulatory
roles within the cell. Loh et al. (2009)
questioned whether these truncated tran-
scripts could mediate the expression of
other genes ‘‘in trans’’.
The authors began with the SAM-ribos-
witch SreA, which regulates the transcrip-
tion of three downstream genes that
encode an ABC-transporter complex. In
nutrient-poor conditions, where SAM
concentrations are expected to be low,
the ABC-transporter is expressed, pre-
sumably leading to nutrient import. In
nutrient-rich conditions, SAM is available
to bind to the SreA riboswitch, which
terminates transcription and leaves
behind a 229 nucleotide RNA fragment.
Loh et al. (2009) deleted the region of the
50-UTR that coded for the riboswitch and
looked for changes in the expression
profiles of other genes. They discovered
that 3 genes were upregulated, while 6
others were downregulated. Loh et al.
(2009) were able to dissect the pathways
by which a SAM-riboswitch could regulate
these genes by focusing on one upregu-
lated gene (lmo2230) and one downregu-
lated gene (lmo0049), and by performing
a great deal of molecular detective work.
Previous work had shown that expres-
sion of lmo2230, a protein homologous
to a bacterial arsenate reductase, is acti-
vated by two regulators, the sigma factor
sB and the virulence regulator PrfA (Milo-
hanic et al., 2003). Through western
blotting, the authors show that deletion
of the SreA riboswitch had no effect on
the levels of sB, but that expression of
PrfA increased two fold. Through a variety
of studies in L. monocytogenes, in an
ectopic system in E. coli, and in vitro,
Loh et al. (2009) make a compelling case
that a 229 nucleotide RNA fragment left
behind by a SAM riboswitch regulates
the expression of PrfA in trans. Since
PrfA is a master virulence regulator,
many of its targets (including lmo2230)
are thus regulated by SAM.
Interestingly, it was previously shown
that the mRNA encoding PrfA has an RNAChemistry & Biology 16, November 25, 2009thermosensor in its 50-UTR that prevents
translation at low temperatures, but allows
it at temperatures that permit infection
(Johansson et al., 2002). Loh et al. (2009)
show that the SreA riboswitch fragment
only interacts with PrfA at higher tem-
peratures, suggesting that the Listeria viru-
lence program is activated most strongly
under conditions that favor infection (e.g.,
body temperature, rich nutrients).
To be sure, there is much more to
discover about the specific mechanisms
that control the virulence programs in
pathogenic bacteria. However, the work
by Loh et al. (2009) answers many impor-
tant questions, raises some new ones,
and reminds us just how versatile an actor
RNA is. Now that the world will be on the
lookout for trans-acting riboswitches,
I suspect that many other RNA ‘‘trans-
actors’’ will be discovered to play critical
roles in biology.
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